Epithelial ovarian cancer

Tanja Pejovic; Kunle Odunsi; Matthew L. Anderson

doi:10.1016/B978-0-12-800684-9.00011-3

Epithelial ovarian cancer

Tanja Pejovic, Kunle Odunsi, Matthew L. Anderson

Obstetrics and Gynecology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Over the past decade, medicine has witnessed an explosion of new insights into the genomic events important for determining a woman’s susceptibility to ovarian cancer. Many of these insights also play a key role in determining clinical ovarian cancer outcomes. This chapter reviews our rapidly evolving understanding of these events. It places particular emphasis on those insights, such as our understanding of inherited syndromes of breast and ovarian cancer, that have dramatically expanded options for ovarian cancer prevention and treatment.

Original language	English (US)
Title of host publication	Genomic and Precision Medicine
Subtitle of host publication	Oncology, Third Edition
Publisher	Elsevier
Pages	173-190
Number of pages	18
ISBN (Electronic)	9780128006849
ISBN (Print)	9780128006535
DOIs	https://doi.org/10.1016/B978-0-12-800684-9.00011-3
State	Published - Jan 1 2022

Keywords

BRCA1/2
Epithelial ovarian cancer
PARP inhibitors
angiogenesis
homologous recombination deficiency
immune response

ASJC Scopus subject areas

Biochemistry, Genetics and Molecular Biology(all)

Access to Document

10.1016/B978-0-12-800684-9.00011-3

Cite this

@inbook{d02ce186ffd44aa1ac641dc4d1a280af,

title = "Epithelial ovarian cancer",

abstract = "Over the past decade, medicine has witnessed an explosion of new insights into the genomic events important for determining a woman{\textquoteright}s susceptibility to ovarian cancer. Many of these insights also play a key role in determining clinical ovarian cancer outcomes. This chapter reviews our rapidly evolving understanding of these events. It places particular emphasis on those insights, such as our understanding of inherited syndromes of breast and ovarian cancer, that have dramatically expanded options for ovarian cancer prevention and treatment.",

keywords = "BRCA1/2, Epithelial ovarian cancer, PARP inhibitors, angiogenesis, homologous recombination deficiency, immune response",

author = "Tanja Pejovic and Kunle Odunsi and Anderson, {Matthew L.}",

year = "2022",

month = jan,

day = "1",

doi = "10.1016/B978-0-12-800684-9.00011-3",

language = "English (US)",

isbn = "9780128006535",

pages = "173--190",

booktitle = "Genomic and Precision Medicine",

publisher = "Elsevier",

}

TY - CHAP

T1 - Epithelial ovarian cancer

AU - Pejovic, Tanja

AU - Odunsi, Kunle

AU - Anderson, Matthew L.

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Over the past decade, medicine has witnessed an explosion of new insights into the genomic events important for determining a woman’s susceptibility to ovarian cancer. Many of these insights also play a key role in determining clinical ovarian cancer outcomes. This chapter reviews our rapidly evolving understanding of these events. It places particular emphasis on those insights, such as our understanding of inherited syndromes of breast and ovarian cancer, that have dramatically expanded options for ovarian cancer prevention and treatment.

AB - Over the past decade, medicine has witnessed an explosion of new insights into the genomic events important for determining a woman’s susceptibility to ovarian cancer. Many of these insights also play a key role in determining clinical ovarian cancer outcomes. This chapter reviews our rapidly evolving understanding of these events. It places particular emphasis on those insights, such as our understanding of inherited syndromes of breast and ovarian cancer, that have dramatically expanded options for ovarian cancer prevention and treatment.

KW - BRCA1/2

KW - Epithelial ovarian cancer

KW - PARP inhibitors

KW - angiogenesis

KW - homologous recombination deficiency

KW - immune response

UR - http://www.scopus.com/inward/record.url?scp=85137898289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85137898289&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800684-9.00011-3

DO - 10.1016/B978-0-12-800684-9.00011-3

M3 - Chapter

AN - SCOPUS:85137898289

SN - 9780128006535

SP - 173

EP - 190

BT - Genomic and Precision Medicine

PB - Elsevier

ER -

Epithelial ovarian cancer

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this